| Guillain–Barré syndrome spectrum associated with COVID-19: an up-to-date systematic review of 73 cases S Abu-Rumeileh, A Abdelhak, M Foschi, H Tumani, M Otto Journal of neurology 268 (4), 1133-1170, 2021 | 542 | 2021 |
| Blood GFAP as an emerging biomarker in brain and spinal cord disorders A Abdelhak, M Foschi, S Abu-Rumeileh, JK Yue, L D’Anna, A Huss, ... Nature Reviews Neurology 18 (3), 158-172, 2022 | 478 | 2022 |
| Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the … M Naghavi, KL Ong, A Aali, HS Ababneh, YH Abate, C Abbafati, ... The Lancet 403 (10440), 2100-2132, 2024 | 455 | 2024 |
| Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950–2021, and the impact of the … AE Schumacher, HH Kyu, A Aali, C Abbafati, J Abbas, ... The Lancet 403 (10440), 1989-2056, 2024 | 296 | 2024 |
| Guillain-Barré syndrome following COVID-19: new infection, old complication? M Padroni, V Mastrangelo, GM Asioli, L Pavolucci, S Abu-Rumeileh, ... Journal of neurology 267, 1877-1879, 2020 | 286 | 2020 |
| Prion-specific and surrogate CSF biomarkers in Creutzfeldt-Jakob disease: diagnostic accuracy in relation to molecular subtypes and analysis of neuropathological correlates of … F Lattanzio, S Abu-Rumeileh, A Franceschini, H Kai, G Amore, I Poggiolini, ... Acta neuropathologica 133, 559-578, 2017 | 177 | 2017 |
| CSF biomarkers of neuroinflammation in distinct forms and subtypes of neurodegenerative dementia S Abu-Rumeileh, P Steinacker, B Polischi, A Mammana, A Bartoletti-Stella, ... Alzheimer's research & therapy 12, 1-15, 2020 | 155 | 2020 |
| The CSF neurofilament light signature in rapidly progressive neurodegenerative dementias S Abu-Rumeileh, S Capellari, M Stanzani-Maserati, B Polischi, ... Alzheimer's research & therapy 10, 1-11, 2018 | 105 | 2018 |
| Neurofilaments as biomarkers in neurological disorders—towards clinical application M Khalil, CE Teunissen, S Lehmann, M Otto, F Piehl, T Ziemssen, ... Nature Reviews Neurology 20 (5), 269-287, 2024 | 86 | 2024 |
| Global, regional, and national burden of stroke and its risk factors, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 VL Feigin, MD Abate, YH Abate, S Abd ElHafeez, F Abd-Allah, ... The Lancet Neurology 23 (10), 973-1003, 2024 | 82 | 2024 |
| The multifaceted role of neurofilament light chain protein in non-primary neurological diseases S Abu-Rumeileh, A Abdelhak, M Foschi, L D'Anna, M Russo, P Steinacker, ... Brain 146 (2), 421-437, 2023 | 73 | 2023 |
| Cerebrospinal fluid biomarkers in patients with frontotemporal dementia spectrum: a single-center study S Abu-Rumeileh, N Mometto, A Bartoletti-Stella, B Polischi, F Oppi, ... Journal of Alzheimer’s Disease 66 (2), 551-563, 2018 | 73 | 2018 |
| Miller‐Fisher syndrome after COVID‐19: neurochemical markers as an early sign of nervous system involvement M Senel, S Abu‐Rumeileh, D Michel, T Garibashvili, K Althaus, ... European Journal of Neurology 27 (11), 2378-2380, 2020 | 72 | 2020 |
| Diagnostic-prognostic value and electrophysiological correlates of CSF biomarkers of neurodegeneration and neuroinflammation in amyotrophic lateral sclerosis S Abu-Rumeileh, V Vacchiano, C Zenesini, B Polischi, S de Pasqua, ... Journal of Neurology 267, 1699-1708, 2020 | 63 | 2020 |
| Diagnostic accuracy of a combined analysis of cerebrospinal fluid t-PrP, t-tau, p-tau, and Aβ 42 in the differential diagnosis of Creutzfeldt-Jakob disease from Alzheimer’s … S Abu Rumeileh, F Lattanzio, M Stanzani Maserati, R Rizzi, S Capellari, ... Journal of Alzheimer's Disease 55 (4), 1471-1480, 2017 | 60 | 2017 |
| Diagnostic value of surrogate CSF biomarkers for Creutzfeldt–Jakob disease in the era of RT-QuIC S Abu-Rumeileh, S Baiardi, B Polischi, A Mammana, A Franceschini, ... Journal of neurology 266, 3136-3143, 2019 | 58 | 2019 |
| Serum interleukin-10 levels correlate with cerebrospinal fluid amyloid beta deposition in Alzheimer disease patients L D'anna, S Abu-Rumeileh, M Fabris, C Pistis, A Baldi, N Sanvilli, F Curcio, ... Neurodegenerative Diseases 17 (4-5), 227-234, 2017 | 56 | 2017 |
| Antemortem CSF Aβ42/Aβ40 ratio predicts Alzheimer's disease pathology better than Aβ42 in rapidly progressive dementias S Baiardi, S Abu‐Rumeileh, M Rossi, C Zenesini, A Bartoletti‐Stella, ... Annals of clinical and translational neurology 6 (2), 263-273, 2019 | 53 | 2019 |
| Global, regional, and national incidence and mortality burden of non-COVID-19 lower respiratory infections and aetiologies, 1990–2021: a systematic analysis from the Global … RG Bender, SB Sirota, LR Swetschinski, RMV Dominguez, A Novotney, ... The Lancet Infectious Diseases 24 (9), 974-1002, 2024 | 52 | 2024 |
| Comparison between plasma and cerebrospinal fluid biomarkers for the early diagnosis and association with survival in prion disease S Abu-Rumeileh, S Baiardi, A Ladogana, C Zenesini, A Bartoletti-Stella, ... Journal of Neurology, Neurosurgery & Psychiatry 91 (11), 1181-1188, 2020 | 49 | 2020 |
Piero ParchiUniversity of Bologna and IRCCS Istituto delle Scienze Neurologiche di BolognaEmail verificata su unibo.it
